Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH’s Translational Science Center Could See Budget Trimmed

Executive Summary

Republicans on appropriations subcommittee again seem concerned about whether NCATS will trample industry toes, which could lead to a more tightened focus for the new NIH center’s funding in the upcoming bill.

You may also be interested in...



NIH Appropriations Flat In House Subcommittee Mark, But Chair Calls It An Increase

Rep. Rehberg says focusing NIH spending on basic research instead of other purposes is effectively a boost; committee battles over funding for comparative effectiveness research.

NIH Translational Science Center Would Get 10% Funding Boost In Senate Bill

Appropriations Committee recommends BARDA receive a 12% increase over its fiscal 2012 appropriations in the report accompanying the Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations bill sent to the floor on a party-line vote of 16-14, June 14.

Bioterror Investor Fund Would Get $20 Mil. Ante Under Senate Appropriations Bill

Funding for the Cures Acceleration Network would also be increased, to $40 million in fiscal 2013, under the legislation marked up by the Appropriations subcommittee; the full committee will work on the bill June 14.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel